Related Experiment Video
Updated: Jul 12, 2025

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Biofilm's Impact on Inflammatory Bowel Diseases
Gopal S Palandurkar1, Sunil Kumar1
1Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Inflammatory bowel disease (IBD) involves gut inflammation influenced by genetics and environment. Research highlights bacterial biofilms in IBD pathogenesis, suggesting new therapeutic targets for improved patient well-being.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- The colon harbors a dense and diverse microbial community crucial for intestinal homeostasis.
- Inflammatory bowel disease (IBD) is characterized by chronic gut inflammation, influenced by genetic and environmental factors.
- Bacterial biofilms and their extracellular matrix play a significant role in IBD pathogenesis and host immune response.
Purpose of the Study:
- To review current knowledge on bacterial biofilm formation in IBD.
- To investigate the incidence of IBD patients, involved bacteria, and molecular mechanisms.
- To explore current and future therapeutic strategies, including probiotics, for managing IBD-associated biofilms.
Main Methods:
- Literature review of studies on IBD and bacterial biofilms.
- Analysis of factors contributing to biofilm development and mucosal colonization in IBD.
- Evaluation of diagnostic and therapeutic approaches targeting gut microbiota and biofilms.
Main Results:
- Bacterial biofilms are implicated in the development and progression of IBD.
- Specific microorganisms and host factors contribute to biofilm formation and immune dysregulation.
- Current research emphasizes disrupting biofilms to improve IBD patient quality of life.
Conclusions:
- Targeting bacterial biofilms presents a promising avenue for novel IBD diagnostics and therapies.
- Further research into biofilm eradication strategies is essential for developing innovative treatment options.
- Understanding the interplay between gut microbiota, biofilms, and the immune system is key to managing IBD.
Related Concept Videos
Biofilms
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

